Description
NY-ESO-1 specific TCR-HEK293 cell line | CHEK-STP114-2Vials| Gentaur Distribution US, UK & Europe
NY-ESO-1, which is also well-known as New York esophageal squamous cell carcinoma 1, is an efficient target for cancer immunotherapy. This antigen is a member of cancer-testis antigens (CTAs) and is highly expressed in various cancers, including melanoma, ovarian, cervical cancer, etc. Adoptive T cell therapy with HLA-A2 restricted NY-ESO-1 transduced CD8+ T cells has improved the clinical response rates and overall survival of treatment-refractory melanoma patients. This cell can specifically recognize HLA-A2/NY-ESO-1.
Species: Human.
Molecule: NY-ESO-1.
Tag: Native.
Format: Liquid.
Application: Binding assay by FACS and cell based ELISA.
Storage Conditions: Frozen in liquid nitrogen.
Shipping Conditions: Dry ice
